Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 4/20 | 0.50 |
| ▸ | THRB | P10828 | 1/20 | 0.47 |
| ▸ | POLB | P06746 | 1/20 | 0.36 |
| ▸ | APEX1 | P27695 | 1/20 | 0.36 |
| ▸ | HTT | P42858 | 1/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.34 |
| ▸ | ACHE | P22303 | 1/20 | 0.34 |
| ▸ | MGLL | Q99685 | 1/20 | 0.32 |
| ▸ | FFAR3 | O14843 | 1/20 | 0.30 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.30 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.30 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.30 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10982125 | 0.90 | TSHR (0.56) | TSHRTHRBPOLBAPEX1HTT | |
| SCHEMBL29516143 | 0.90 | THRB (0.46) | TSHRTHRBPOLBAPEX1HTT | |
| SCHEMBL5851844 | 0.90 | TSHR (0.53) | TSHRTHRBPOLBAPEX1HTT | |
| SCHEMBL368972 | 0.87 | TSHR (0.46) | TSHRTHRBPOLBAPEX1HTT | |
| SCHEMBL5505311 | 0.86 | THRB (0.50) | TSHRTHRBPOLBAPEX1HTT | |
| SCHEMBL9776625 | 0.85 | TSHR (0.45) | TSHRTHRBPOLBAPEX1HTT | |
| SCHEMBL8678908 | 0.84 | TSHR (0.51) | TSHRTHRBPOLBAPEX1HTT | |
| Propanol SCHEMBL28040663 | 0.84 | TSHR (0.62) | TSHRTHRBPOLBAPEX1HTT | |
| Butane SCHEMBL9100855 | 0.84 | TSHR (0.62) | TSHRTHRBPOLBAPEX1HTT | |
| Methacrylic Acid SCHEMBL9453862 | 0.84 | THRB (0.53) | TSHRTHRBPOLBAPEX1HTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 47 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9248216-B2 | Medical devices for delivery of therapeutic agents | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2016-02-02 | — | — | US | disclosed |
| US-20130164348-A1 | MEDICAL DEVICES FOR DELIVERY OF THERAPEUTIC AGENTS | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2013-06-27 | — | — | US | disclosed |
| US-8361143-B2 | Medical devices for delivery of therapeutic agents | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2013-01-29 | — | — | US | disclosed |
| US-8211455-B2 | Implantable or insertable medical devices for controlled delivery of a therapeutic agent | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2012-07-03 | — | — | US | disclosed |
| US-20110123594-A1 | Implantable or Insertable Medical Devices For Controlled Delivery of a Therapeutic Agent | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2011-05-26 | — | — | US | disclosed |
| US-7939094-B2 | Comprises implantable/insertable implants (catheter, stents) | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2011-05-10 | — | — | US | disclosed |
| US-7923509-B2 | Drug delivery compositions and medical devices containing block copolymer | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2011-04-12 | — | — | US | disclosed |
| US-7901702-B2 | Implantable or insertable medical devices for controlled delivery of a therapeutic agent | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2011-03-08 | — | — | US | disclosed |
| US-20100092540-A1 | DRUG DELIVERY COMPOSITIONS AND MEDICAL DEVICES CONTAINING BLOCK COPOLYMER | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2010-04-15 | — | — | US | disclosed |
| US-7622530-B2 | Drug delivery compositions and medical devices containing block copolymer | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2009-11-24 | — | — | US | disclosed |
| US-20030228346-A1 | Sustained release of superoxide dismutase mimics from implantable or insertable medical devices | BOSTON SCIENTIFIC SCIMED, INC. | 2003-12-11 | — | — | US | disclosed |
| WO-2003090806-A1 | MODULATION OF THERAPEUTIC AGENT RELEASE FROM A POLYMERIC CARRIER USING SOLVENT-BASED TECHNIQUES | SCIMED LIFE SYSTEMS, INC. (US) | 2003-11-06 | — | — | WO | disclosed |
| US-20030203000-A1 | Modulation of therapeutic agent release from a polymeric carrier using solvent-based techniques | BOSTON SCIENTIFIC SCIMED, INC. | 2003-10-30 | — | — | US | disclosed |
| US-20030171496-A1 | Drug delivery compositions and medical devices containing block copolymer | PINCHUK LEONARD (US) | 2003-09-11 | — | — | US | disclosed |
| EP-1341565-A2 | DRUG DELIVERY COMPOSITIONS AND COATED MEDICAL DEVICES | Boston Scientific Limited (BB) | 2003-09-10 | — | — | EP | disclosed |
| WO-2003061718-A2 | MEDICAL ARTICLES HAVING ENZYMATIC SURFACES FOR LOCALIZED THERAPY | SCIMED LIFE SYSTEMS, INC. (US) | 2003-07-31 | — | — | WO | disclosed |
| US-20030138415-A1 | Medical articles having enzymatic surfaces for localized therapy | BOSTON SCIENTIFIC SCIMED, INC. | 2003-07-24 | — | — | US | disclosed |
| US-6545097-B2 | Biocompatible block copolymer comprising one or more elastomeric blocks and one or more thermoplastic blocks connected by a seed polymer | SCIMED LIFE SYSTEMS, INC. | 2003-04-08 | — | — | US | disclosed |
| US-20020107330-A1 | Drug delivery compositions and medical devices containing block copolymer | BOSTON SCIENTIFIC SCIMED, INC. | 2002-08-08 | — | — | US | disclosed |
| WO-2002047731-A2 | DRUG DELIVERY COMPOSITIONS AND COATED MEDICAL DEVICES | SCIMED LIFE SYSTEMS, INC. (US) | 2002-06-20 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100092540-A1 | DRUG DELIVERY COMPOSITIONS AND MEDICAL DEVICES CONTAINING BLOCK COPOLYMER | VEGFA, VMA21, ABCB1 | TSHR 3134/4885THRB 487/4885POLB 320/4885 |
| US-20030203000-A1 | Modulation of therapeutic agent release from a polymeric carrier using solvent-based techniques | ABCB11, LPXN, LIPA | TSHR 1872/4885THRB 2666/4885POLB 1308/4885 |
| US-20030228346-A1 | Sustained release of superoxide dismutase mimics from implantable or insertable medical devices | SOD1, SOD3, CAT | TSHR 3220/4885THRB 3358/4885POLB 1790/4885 |
| US-20030138415-A1 | Medical articles having enzymatic surfaces for localized therapy | CYP21A2, CYP17A1, MGAM | TSHR 2347/4885THRB 2797/4885POLB 3376/4885 |
| US-20110123594-A1 | Implantable or Insertable Medical Devices For Controlled Delivery of a Therapeutic Agent | MIF, PAICS, IDUA | TSHR 2108/4885THRB 1955/4885POLB 4396/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.